Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin thromboprophylaxis after hepatic resection
ChiCTR1800017385Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Incidence of venous thromboembolism. Started Jul 2018; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR1800017385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017385.